Home > Healthcare > Medical Devices > Implantable Devices > Bioimplants Market
Bioimplants Market size in 2023 was valued at USD 132 billion and is anticipated to experience growth at a CAGR of 8.2% from 2024 to 2032. High market growth can be attributed to the increasing prevalence of chronic diseases and conditions, such as cardiovascular diseases, orthopedic disorders, and ophthalmic diseases, which require bioimplants for treatment and management.
Additionally, the rising geriatric population, which is more susceptible to these chronic conditions, is further driving the demand for bioimplants. Further, technological advancements in the field, such as the development of biocompatible materials and 3D printing techniques, are also fueling market growth by improving the effectiveness and lifespan of bioimplants. Moreover, the growing preference for minimally invasive surgeries, which require bioimplants for procedures like joint replacements and dental implants, is contributing to market expansion.
Bioimplants are medical devices that are implanted into the body to replace a missing biological structure, support a damaged biological structure, or enhance an existing biological structure. These implants can be made from a variety of materials, including metals, ceramics, and polymers, and they are designed to integrate with the body's tissues or perform specific functions within the body.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Bioimplants Market Size in 2023: | USD 132 Billion |
Forecast Period: | 2024 – 2032 |
Forecast Period 2024 – 2032 CAGR: | 8.2% |
2024 – 2032 Value Projection: | USD 263.8 Billion |
Historical Data for: | 2021 – 2023 |
No. of Pages: | 232 |
Tables, Charts & Figures: | 403 |
Segments covered: | Type, Material Type, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|